Table of Contents
Summary
- Introduction
- Key global markets
- Key therapeutic markets
- Key products
- Key companies
- Key trends and opportunities
Chapter 1. Introduction
- Global pharmaceutical market
- Report overview
- Methodology
- Sources
- Structure
Chapter 2. Key global markets
- Key pharmaceutical markets
- US pharmaceutical market
- US purchasing channels
- US retail drug market
- US therapy areas
- US market leaders
- European pharmaceutical market
- European retail drug market
- European therapy areas
- Japanese pharmaceutical market
Chapter 3. Key therapeutic markets
- Key therapy areas
- Retail drug therapy areas
- Cardiovascular therapy area
- Cardiovascular markets
- Cardiovascular blockbusters
- Central nervous system therapy area
- Central nervous system markets
- Central nervous system blockbusters
- Alimentary/ metabolism therapy area
- Alimentary/ metabolism markets
- Alimentary/ metabolism blockbusters
- Respiratory therapy area
- Respiratory markets
- Respiratory blockbusters
- Anti-infectives therapy area
- Anti-infectives markets
- Anti-infectives blockbusters
- Musculo-skeletal therapy area
- Musculo-skeletal markets
- Musculo-skeletal blockbusters
- Cytostatics therapy area
- Cytostatics markets
- Cytostatics blockbusters
Chapter 4. Key products
- Leading products
- Lipitor (atorvastatin)
- Plavix (clopidogrel)
- Advair/ Seretide (fluticasone; salmeterol)
- Norvasc (amlodipine)
- Nexium (esomeprazole)
- Zocor (simvastatin)
- Zyprexa (olanzapine)
- Prevacid (lansoprazole)
- Diovan/ Co-Diovan (valsartan/ hydrochlorothiazide)
- Enbrel (etanercept)
- Blockbuster trends
- Blockbusters by drug type
- Blockbusters by therapy area
- Blockbusters by company
Chapter 5. Key companies
- Major pharmaceutical companies
- Major company financials
- Major company locations
- Top 10 pharmaceutical companies
- Top 10 company financials
- Top 10 company value drivers
- Leading pharmaceutical companies
- Pfizer
- Sanofi-Aventis
- GlaxoSmithKline
- AstraZeneca
- Johnson and Johnson
- Roche
- Merck & Co
- Novartis
- Wyeth
- Bristol-Myers Squibb
Chapter 6. Key trends and opportunities
- Global market forecasts
- The US market
- The European market
- The Japanese market
- Other markets
- Key therapy area forecasts
- Cardiovascular market
- Central nervous system market
- Alimentary/ metabolism market
- Anti-infectives market
- Respiratory market
- Key product forecasts
- Lipitor (atorvastatin)
- Plavix (clopidogrel)
- Advair/ Seretide (fluticasone; salmeterol)
- Norvasc (amlodipine)
- Nexium (esomeprazole)
- Zocor (simvastatin)
- Zyprexa (olanzapine)
- Prevacid (lansoprazole)
- Diovan/ Co-Diovan (valsartan; hydrochlorothiazide)
- Enbrel (etanercept)
- Key company forecasts
- Pfizer
- Sanofi-Aventis
- GlaxoSmithKline
- AstraZeneca
- Johnson and Johnson
- Roche
- Merck & Co
- Novartis
- Wyeth
- Bristol-Myers Squibb
Appendix
- Proprietary data sources
- Company Trends Database
- Top 100 pharmaceutical products
- Top 64 pharmaceutical companies
List of Figures
- Figure 1: Global pharmaceutical market, 1999-2005
- Figure 2: Report structure
- Figure 3: Global pharmaceutical market share by region, 2005
- Figure 4: Global pharmaceutical market by region, 2003-2005
- Figure 5: US pharmaceutical market, 2003-2005
- Figure 6: US pharmaceutical market share by purchasing channel,
- Figure 7: US pharmaceutical market by purchasing channel, 2003-
- Figure 8: US retail pharmaceutical market, 2003-2005
- Figure 9: US retail pharmaceutical market share by therapy area, 2005
- Figure 10: US retail pharmaceutical market by therapy area, 2003-2005
- Figure 11: Top 10 products by US pharmaceutical sales, 2005
- Figure 12: Top 10 companies by US pharmaceutical sales,
- Figure 13: Top 10 companies by share of US pharmaceutical sales,
- Figure 14: European pharmaceutical market, 2003-2005
- Figure 15: European pharmaceutical market share by country, 2005
- Figure 16: European top 5 retail pharmaceutical market, 2003-2005
- Figure 17: European top 5 retail pharmaceutical market share by country,
2005
- Figure 18: European top 5 retail pharmaceutical market by country,
2003-2005
- Figure 19: European top 5 retail pharmaceutical market share by therapy
area, 2005
- Figure 20: European top 5 retail pharmaceutical market by therapy area,
2003-2005
- Figure 21: Japanese pharmaceutical market, 2003-2005
- Figure 22: Japanese pharmaceutical market share by therapy area, 2005
- Figure 23: Japanese pharmaceutical market by therapy area, 2003-2005
- Figure 24: Global pharmaceutical market by therapy area, 2005
- Figure 25: Top 10 product classes by global pharmaceutical sales, 2005
- Figure 26: Global retail pharmaceutical market share by therapy area, 2005
- Figure 27: Global retail pharmaceutical market by therapy area, 2003-
- Figure 28: Cardiovascular retail pharmaceutical market, 2003-2005
- Figure 29: Cardiovascular retail pharmaceutical market share by country,
2005
- Figure 30: Cardiovascular retail pharmaceutical market by country,
2003-2005
- Figure 31: Central nervous system retail pharmaceutical market, 2003-2005
- Figure 32: Central nervous system retail pharmaceutical market share by
country, 2005
- Figure 33: Central nervous system retail pharmaceutical market by country,
2003-2005
- Figure 34: Alimentary/ metabolism retail pharmaceutical market, 2003-2005
- Figure 35: Alimentary/ metabolism retail pharmaceutical market share by
country, 2005
- Figure 36: Alimentary/ metabolism retail pharmaceutical market by country,
2003-2005
- Figure 37: Respiratory retail pharmaceutical market, 2003-2005
- Figure 38: Respiratory retail pharmaceutical market share by country, 2005
- Figure 39: Respiratory retail pharmaceutical market by country, 2003-2005
- Figure 40: Anti-infectives retail pharmaceutical market, 2003-2005
- Figure 41: Anti-infectives retail pharmaceutical market share by country,
2005
- Figure 42: Anti-infectives retail pharmaceutical market by country,
2003-2005
- Figure 43: Musculo-skeletal retail pharmaceutical market, 2003-2005
- Figure 44: Musculo-skeletal retail pharmaceutical market share by country,
2005
- Figure 45: Musculo-skeletal retail pharmaceutical market by country,
2003-2005
- Figure 46: Cytostatics retail pharmaceutical market, 2003-2005
- Figure 47: Cytostatics retail pharmaceutical market share by country, 2005
- Figure 48: Cytostatics retail pharmaceutical market by country, 2003-2005
- Figure 49: Blockbuster drug sales share by drug type, 2005
- Figure 50: Blockbuster drug sales share by lifecycle stage, 2005
- Figure 51: Blockbuster drug sales share by therapy area, 2005
- Figure 52: Blockbuster drug sales share by company, 2005
- Figure 53: Major companies pharmaceutical sales, 2003-2005
- Figure 54: Major companies revenue share allocation, 2005
- Figure 55: Major companies revenue allocation, 2003-2005
- Figure 56: Major companies pharmaceutical sales by location, 2005
- Figure 57: Top 10 pharma companies pharmaceutical sales, 2003-2005
- Figure 58: Top 10 pharma companies by global pharmaceutical sales, 2005
- Figure 59: Top 10 biotechnology companies by global revenues, 2005
- Figure 60: Top 10 pharma companies revenue share allocation, 2005
- Figure 61: Top 10 pharma companies revenue allocation, 2003-2005
- Figure 62: Key value drivers for top 10 pharma companies (income), 2005
- Figure 63: Key value drivers for top 10 pharma companies (sales), 2005
- Figure 64: Key value drivers for top 10 pharma companies (sales/ R&D), 2005
- Figure 65: Pfizer therapy area sales, 2003-2005
- Figure 66: Sanofi-Aventis blockbuster therapy area sales, 2003-2005
- Figure 67: GlaxoSmithKline therapy area sales, 2003-2005
- Figure 68: AstraZeneca therapy area sales, 2003-2005
- Figure 69: Johnson and Johnson blockbuster therapy area sales, 2003-2005
- Figure 70: Roche therapy area sales, 2003-2005
- Figure 71: Merck & Co blockbuster therapy area sales, 2003-2005
- Figure 72: Novartis therapy area sales, 2003-2005
- Figure 73: Wyeth blockbuster therapy area sales, 2003-2005
- Figure 74: Bristol-Myers Squibb therapy area sales, 2005
- Figure 75: Global pharmaceutical market forecast, 2003-2010
- Figure 76: Global pharmaceutical market forecast by regions, 2003-2010
- Figure 77: Top 10 pharmaceutical drugs by forecast sales, 2010
- Figure 78: Lipitor (atorvastatin) forecast sales, 2003-2010
- Figure 79: Plavix (clopidogrel) forecast sales, 2003-2010
- Figure 80: Advair/ Seretide (fluticasone; salmeterol) forecast sales, 2003-
- Figure 81: Norvasc (amlodipine) forecast sales, 2003-2010
- Figure 82: Nexium (esomeprazole) forecast sales, 2003-2010
- Figure 83: Zocor (simvastatin) forecast sales, 2003-2010
- Figure 84: Zyprexa (olanzapine) forecast sales, 2003-2010
- Figure 85: Prevacid (lansoprazole) forecast sales, 2003-2010
- Figure 86: Diovan/ Co-Diovan (valsartan; hydrochlorothiazide) forecast
sales, 2003-2010
- Figure 87: Enbrel (etanercept) forecast sales, 2003-2010
List Of Tables
- Table 1: Global pharmaceutical market trends by region, 2003-2005
- Table 2: US pharmaceutical market trends by purchasing channel, 2003-2005
- Table 3: US retail pharmaceutical market trends by therapy area, 2003-2005
- Table 4: Top 10 products trends by US pharmaceutical sales, 2003-2005
- Table 5: European top 5 retail pharmaceutical market trends by country,
2003-2005
- Table 6: European top 5 retail pharmaceutical market trends by therapy
area, 2003-2005
- Table 7: Japanese pharmaceutical market trends by therapy area, 2003-2005
- Table 8: Top 10 product classes trends by global pharmaceutical sales,
2004-2005
- Table 9: Global retail pharmaceutical market trends by therapy area,
2003-2005
- Table 10: Cardiovascular retail pharmaceutical market trends by country,
2003-2005
- Table 11: Cardiovascular blockbuster drug sales, 2003-2005
- Table 12: Central nervous system retail pharmaceutical market trends by
country, 2003-2005
- Table 13: Central nervous system blockbuster drug sales, 2003-2005
- Table 14: Alimentary/ metabolism retail pharmaceutical market trends by
country, 2003-2005
- Table 15: Alimentary/ metabolism blockbuster drug sales, 2003-2005
- Table 16: Respiratory retail pharmaceutical market trends by country,
2003-2005
- Table 17: Respiratory blockbuster drug sales, 2003-2005
- Table 18: Anti-infectives retail pharmaceutical market trends by country,
2003-2005
- Table 19: Anti-infectives blockbuster drug sales, 2003-2005
- Table 20: Musculo-skeletal retail pharmaceutical market trends by country,
2003-2005
- Table 21: Musculo-skeletal blockbuster drug sales, 2003-2005
- Table 22: Cytostatics retail pharmaceutical market trends by country,
2003-2005
- Table 23: Cytostatics blockbuster drug sales, 2003-2005
- Table 24: Top 20 products by global pharmaceutical sales, 2003-2005
- Table 25: Lipitor (atorvastatin) profile, 2005
- Table 26: Plavix (clopidogrel) profile, 2005
- Table 27: Advair/ Seretide (fluticasone; salmeterol) profile, 2005
- Table 28: Norvasc (amlodipine) profile, 2005
- Table 29: Nexium (esomeprazole) profile, 2005
- Table 30: Zocor (simvastatin) profile, 2005
- Table 31: Zyprexa (olanzapine) profile, 2005
- Table 32: Prevacid (lansoprazole) profile, 2005
- Table 33: Diovan/ Co-Diovan (valsartan/ hydrochlorothiazide) profile, 2005
- Table 34: Enbrel (etanercept) profile, 2005
- Table 35: Top 10 blockbuster products by global pharmaceutical sales
growth, 2003-2005
- Table 36: Top 10 blockbuster products by declining global pharmaceutical
sales, 2003-2005
- Table 37: New blockbuster products, 2003-2005
- Table 38: Major companies revenue allocation trends, 2003-2005
- Table 39: Top 10 pharma companies by global pharmaceutical sales, 2003-2005
- Table 40: Top 10 biotechnology companies by global revenues, 2003-2005
- Table 41: Top 10 pharma companies revenue allocation trends, 2003-2005
- Table 42: Pfizer profile, 2005
- Table 43: Pfizer blockbuster sales, 2003-2005
- Table 44: Sanofi-Aventis profile, 2005
- Table 45: Sanofi-Aventis blockbuster sales, 2003-2005
- Table 46: GlaxoSmithKline profile, 2005
- Table 47: GlaxoSmithKline blockbuster sales, 2003-2005
- Table 48: AstraZeneca profile, 2005
- Table 49: AstraZeneca blockbuster sales, 2003-2005
- Table 50: Johnson and Johnson profile, 2005
- Table 51: Johnson and Johnson blockbuster sales, 2003-2005
- Table 52: Roche profile, 2005
- Table 53: Roche blockbuster sales, 2003-2005
- Table 54: Merck & Co profile, 2005
- Table 55: Merck & Co blockbuster sales, 2003-2005
- Table 56: Novartis profile, 2005
- Table 57: Novartis blockbuster sales, 2003-2005
- Table 58: Wyeth profile, 2005
- Table 59: Wyeth blockbuster sales, 2003-2005
- Table 60: Bristol-Myers Squibb profile, 2005
- Table 61: Bristol-Myers Squibb blockbuster sales, 2003-2005
- Table 62: Global pharmaceutical market forecast by regions, 2003-2010
- Table 63: Global pharmaceutical market forecast by therapy area, 2005-2010
- Table 64: Top 10 pharmaceutical drugs forecast, 2003-2010
- Table 65: Top 10 pharmaceutical companies forecast, 2005-2010
- Table 66: Top 100 products by global pharmaceutical sales, 2003-2005
- Table 67: Top 64 companies by global pharmaceutical sales, 2003-2005
|
Related Report
|
View Cart
